Shannon N. Mostyn
Affiliations: | University of Sydney, Camperdown, New South Wales, Australia |
Google:
"Shannon Mostyn"Mean distance: (not calculated yet)
Parents
Sign in to add mentorRenae Monique Ryan | grad student | 2014-2018 | University of Sydney |
Robert J. Vandenberg | grad student | 2014-2018 | University of Sydney |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Wilson BS, Peiser-Oliver J, Gillis A, et al. (2022) . The Journal of Pharmacology and Experimental Therapeutics |
Wilson KA, Mostyn SN, Frangos ZJ, et al. (2021) The allosteric inhibition of glycine transporter 2 by bioactive lipid analgesics is controlled by penetration into a deep lipid cavity. The Journal of Biological Chemistry. 100282 |
Mostyn SN, Sarker S, Muthuraman P, et al. (2020) A photoswitchable ORG25543 congener enables optical control of glycine transporter 2. Acs Chemical Neuroscience |
Mostyn SN, Wilson KA, Schumann-Gillett A, et al. (2019) Identification of an allosteric binding site on the human glycine transporter, GlyT2, for bioactive lipid analgesics. Elife. 8 |
Mostyn SN, Rawling T, Mohammadi S, et al. (2019) Development of an N-acyl amino acid that selectively inhibits the glycine transporter 2 to produce analgesia in a rat model of chronic pain. Journal of Medicinal Chemistry |
Mostyn SN, Wilson KA, Schumann-Gillett A, et al. (2019) Author response: Identification of an allosteric binding site on the human glycine transporter, GlyT2, for bioactive lipid analgesics Elife |
Carland JE, Thomas M, Mostyn SN, et al. (2017) Molecular Determinants for Substrate Interactions with the Glycine Transporter GlyT2. Acs Chemical Neuroscience |
Mostyn SN, Carland JE, Shimmon S, et al. (2017) Synthesis and Characterization of Novel Acyl-Glycine Inhibitors of GlyT2. Acs Chemical Neuroscience |
Vandenberg RJ, Mostyn SN, Carland JE, et al. (2015) Glycine Transporter2 Inhibitors: Getting the balance right. Neurochemistry International |